News and Updates

Discover how simulation-guided clinical trials and digital twin technology are revolutionizing drug development and accelerating life-saving innovations.

The FDA is tightening oversight on global drug manufacturing with new registration updates and increased scrutiny of foreign plants. Read the details here.

Oncolytics Biotech reaches a major FDA milestone for its oncolytic virus, pelareorep, clearing the path for pivotal clinical trial advancement.

New research shows that simple digital check-ins significantly improve cancer treatment outcomes and patient quality of life. Learn how remote monitoring works.

Discover how new FDA transparency standards, protocol-centric recruitment, and Medical Affairs integration are reshaping the future of clinical trials.

Serina Therapeutics completes sentinel dosing for SER-252 in its Phase Ib trial. Learn how this innovative polymer-drug conjugate aims to improve treatment.

GSK and Hansoh Pharma report success in a Chinese Phase III trial for a new SCLC antibody-drug conjugate, marking a major leap in targeted lung cancer care.

New Phase 1 trial results reveal a novel inhibitor targeting GNAQ and GNA11-mutant melanomas, marking a major step forward in precision cancer therapy.

Discover how mid-study CRO mergers create operational risks for clinical sites, from payment delays to staff turnover, and how to protect your trial data.

New clinical data confirms lecanemab’s subcutaneous autoinjector is bioequivalent to IV infusion, promising a simpler treatment path for Alzheimer’s patients.